Chief Scientific Officer

Hybridize: a new perspective

Treating kidney diseases with RNA-based therapies



About us


“Do you want to join us on our journey to change the lives of millions of kidney patients?”


Kidney disease is a major problem. Worldwide 1:10 people are suffering from chronic kidney disease (CKD). A progressive clinical unmet need that results in kidney failure with a growing number of people needing to rely on dialysis to survive. It is therefore the 8th leading cause of death in Western society.


We are Hybridize Therapeutics. We are a growing Biotech start-up on the forefront of developing innovative RNA-based therapies for kidney patients. We are driven to make a difference and prevent people from ending up with the severe consequences of kidney failure. We believe RNA therapeutics are the perfect modality to treat kidney disease. Our deep expertise & network in the field of RNA therapeutics will help us be pioneers in this field. Will you join us on our mission?


We are looking for extraordinary people who:

  1. Are inspired by our mission: to prevent people ending up with kidney failure
  2. Love to be creative, but are also critical thinkers, real pioneers
  3. Want to work in a fast paced, start-up environment with a strong focus on R&D
  4. Are looking for a tight and close team, who also love an occasional drink or dinner



Position: Chief Scientific Officer (full-time)


Role description

We are looking for our company’s chief visionary scientist as a critical expansion of the management. The CSO understands open innovation in a young biotech firm and has deep experience in leading a development program to the clinic. The CSO keeps oversight over the entire pipeline strategy but is also pragmatic removing roadblocks where needed. The CSO works closely with Hybridize’s CIO and internal scientists and with a broad network of academic labs and companies globally. We are seeking a seasoned leader keeping us at the forefront of emerging fields of biology.


Key responsibilities

  1. Steers strategy for portfolio expansion
  2. Enable intellectual property expansion in emerging fields of RNA biology
  3. Implement new research programs/technologies in close collaboration with internal and external resources
  4. Expand external (academic) network of Hybridize
  5. Strong steering role in short and long term goals and overall scientific strategy
  6. Support the CEO in financial rounds
  7. Enable a culture of rigorous scientific work
  8. Significantly contribute to the further development and maturation of Hybridize Therapeutics
  9. Further the product development of existing and partnered pipeline


Your experience / qualifications

  1. Ph.D. in Biology or Pharmacology
  2. >15 years of experience as allrounder Sr Scientist in pharma/biotech environment, including startup experience
  3. Proven track record in drug discovery of RNA-based products/technology
  4. Significant experience with building out IP/portfolio
  5. Track record in fundraising up to Series A
  6. Expertise in delivering drug discovery projects from target validation to IND-stages
  7. Understanding of kidney disease or other disease biology and disease-relevant signaling pathways
  8. Ability to provide guidance and shape strategy for science in an evolving highly dynamic biotech environment
  9. Passion for science
  10. Visionary
  11. Persistent
  12. Flexible, enjoys constantly changing environment
  13. Systematic way of working
  14. Enjoys challenges

If you would like to know more about Hybridize Therapeutics, this position and our offer, feel free to contact us via or through the contact form below